Top

Published in:

01-11-2019 | Editorial

Consultation on UTUC Stockholm 2018

Authors: Marianne Brehmer, Palle Osther

Published in: World Journal of Urology | Issue 11/2019

Excerpt

Upper tract urothelial carcinoma (UTUC) is a rare but lethal disease. About 60% of tumours are invasive at the time of diagnosis. Radical nephroureterectomy (RNU) has been the standard treatment of UTUC. However, a number of studies have indicated that kidney-sparing surgery (KSS) and treatment with radical nephroureterectomy (RNU) offer equivalent long-term CSS if the right patients are selected [1, 2]. …

Grasso M, Fishman AI, Cohen J, Alexander B (2012) Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients. BJU Int 110(11):1618–1626CrossRef

Cutress ML, Stewart GD, Zakikhani P, Phipps S, Thomas BG, Tolley DA (2012) Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review. BJU Int 110(5):614–628CrossRef

Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M et al (2018) European association of urology guidelines on upper urinary tract urothelial carcinoma: 2017 update. Eur Urol 73(1):111–122CrossRef

Holmäng S, Johansson SL (2005) Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system. Urology 66(2):274–278CrossRef

Elawdy MM, Taha DE, Elbaset MA, Abouelkheir RT, Osman Y (2016) Histopathologic characteristics of upper tract urothelial carcinoma with an emphasis on their effect on cancer survival: a single-institute experience with 305 patients with long-term follow-up. Clin Genitourin Cancer 14(6):e609–e615CrossRef

Villa L, Haddad M, Capitanio U, Somani BK, Cloutier J, Doizi S et al (2018) Which patients with upper tract urothelial carcinoma can be safely treated with flexible ureteroscopy with holmium:YAG laser photoablation? Long-term results from a high volume institution. J Urol 199(1):66–73CrossRef

Smith AK, Stephenson AJ, Lane BR, Larson BT, Thomas AA, Gong MC et al (2011) Inadequacy of biopsy for diagnosis of upper tract urothelial carcinoma: implications for conservative management. Urology 78(1):82–86CrossRef

Wang JK, Tollefson MK, Krambeck AE, Trost LW, Thompson RH (2012) High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology 79(3):615–619CrossRef

Dev HS, Poo S, Armitage J, Wiseman O, Shah N, Al-Hayek S (2017) Investigating upper urinary tract urothelial carcinomas: a single-centre 10-year experience. World J Urol 35(1):131–138CrossRef

10.

Kammerer-Jacquet SF, Mathieu R, Peyronnet B, Rioux-Leclercq N, Bensalah K (2017) Genomics in upper tract urothelial carcinoma. Curr Opin Urol 27(1):35–40CrossRef

11.

Fojecki G, Magnusson A, Traxer O, Baard J, Osther PJS, Jaremko G et al (2019) Consultation on UTUC, stockholm 2018 aspects of diagnosis of upper tract urothelial carcinoma. World J Urol. https://doi.org/10.1007/s00345-019-02732-8 CrossRefPubMed

12.

Jung H, Giusti G, Fajkovic H, Herrmann T, Jones R, Straub M et al (2019) Consultation on UTUC, stockholm 2018: aspects of treatment. World J Urol. https://doi.org/10.1007/s00345-019-02811-w CrossRefPubMedPubMedCentral

13.

Hasan MN, Rouprêt M, Keeley F, Cracco C, Jones R, Straub M et al (2019) Consultation on UTUC, stockholm 2018 aspects of risk stratification: long-term results and follow-up. World J Urol. https://doi.org/10.1007/s00345-019-02739-1 CrossRefPubMed

14.

Malm C, Grahn A, Jaremko G, Tribukait B, Brehmer M (2019) Predicting invasiveness and disease-specific survival in upper tract urothelial carcinoma: identifying relevant clinical tumour characteristics. World J Urol. https://doi.org/10.1007/s00345-019-02760-4 CrossRefPubMed

15.

Grahn A, Tanaka N, Uhlén P, Brehmer M (2019) Volumetric imaging: a potential tool to stage upper tract urothelial carcinoma. World J Urol. https://doi.org/10.1007/s00345-019-02682-1 CrossRefPubMed

16.

Keller EX, Doizi S, Villa L, Traxer O (2019) Which flexible ureteroscope is the best for upper tract urothelial carcinoma treatment? World J Urol. https://doi.org/10.1007/s00345-019-02675-0 CrossRefPubMed

17.

Campi R, Cotte J, Sessa F, Seisen T, Tellini R, Amparore D et al (2019) Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience. World J Urol. https://doi.org/10.1007/s00345-019-02790-y CrossRefPubMed

18.

Vartolomei MD, Iwata T, Roth B, Kimura S, Mathieu R, Ferro M et al (2019) Impact of alcohol consumption on the risk of developing bladder cancer: a systematic review and meta-analysis. World J Urol. https://doi.org/10.1007/s00345-019-02825-4 CrossRefPubMed

Title: Consultation on UTUC Stockholm 2018
Authors: Marianne Brehmer
Palle Osther
Publication date: 01-11-2019
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 11/2019
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-019-02932-2

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Consultation on UTUC Stockholm 2018

Excerpt

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2019

Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience

Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer

Optimal sequencing strategy using docetaxel and androgen receptor axis-targeted agents in patients with castration-resistant prostate cancer: utilization of neutrophil-to-lymphocyte ratio

Medical dissolution therapy for the treatment of uric acid nephrolithiasis

A systematic review of contemporary management of oligometastatic prostate cancer: fighting a challenge or tilting at windmills?

Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study